Company / Operating Income per Share
Olema Pharmaceuticals, Inc. Operating Income per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.42
FY2024
5-year range
-$3.07 / -$1.81
FY2020-FY2024
Trend
-4.4%
vs FY2023
Sector context
#127 of 201
Health Care
What the data says
At $-2.42, Olema Pharmaceuticals, Inc.'s operating income per share ranks #127 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 6 years, ranging from $-3.07 in FY2020 to $-1.67 in FY2019.
Based on SEC 10-K filings.
-2.42 in FY2024.
Improved from $-2.68 to $-2.42 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#127 of 201 in Health CareTop 63% of 201This company -$2.42 Sector average -$28.56
▼
+91.5% above sector average
Key checks
Key Insights
- In FY2024, operating income per share decreased 4.4% year-over-year.
- Ranks #127 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2019.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.42 | -4.4% |
| FY2023 | -$2.32 | +13.3% |
| FY2022 | -$2.68 | -47.9% |
| FY2021 | -$1.81 | +41.0% |
| FY2020 | -$3.07 | -83.9% |
| FY2019 | -$1.67 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026